Mark W. Parrish - 01 Jun 2025 Form 4 Insider Report for OMNICELL, INC. (OMCL)

Role
Director
Signature
/s/ Vijay Biligiri, Attorney-in-Fact for Mark W. Parrish
Issuer symbol
OMCL
Transactions as of
01 Jun 2025
Net transactions value
$0
Form type
4
Filing time
03 Jun 2025, 16:12:37 UTC
Previous filing
10 Mar 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Quoteable Key Fact

"Mark W. Parrish filed Form 4 for OMNICELL, INC. (OMCL) on 03 Jun 2025."

Quick Takeaways

  • This page summarizes Mark W. Parrish's Form 4 filing for OMNICELL, INC. (OMCL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 03 Jun 2025, 16:12.

What Changed

  • Previous filing in this sequence was filed on 10 Mar 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PARRISH MARK W Director OMNICELL, INC, 4220 NORTH FREEWAY, FORTH WORTH /s/ Vijay Biligiri, Attorney-in-Fact for Mark W. Parrish 03 Jun 2025 0001236452

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMCL Common Stock Award $0 +6,828 +12% $0.000000 65,255 01 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .